4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-359189
Chief Development Officer sold 404 shares at $49.90 ($20,160)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yeleswaram Krishnaswamy Chief Development Officer | 2026-08-19 | Sale 10b5-1 | −404 | $49.90 | $20,160 | 246,022 | D |
| Open-market sales · 404 sh · avg $49.90 · $20,160 | |||||||
Loading xslF345X06/ownership.xml…